More about

Gynecologic Cancer

News
September 21, 2021
1 min read
Save

FDA approves Tivdak for advanced cervical cancer

FDA approves Tivdak for advanced cervical cancer

The FDA granted accelerated approval to tisotumab vedotin-tftv for certain women with advanced cervical cancer.

News
September 15, 2021
1 min read
Save

FDA clears IND application for T-cell receptor therapy to treat epithelial cancers

FDA clears IND application for T-cell receptor therapy to treat epithelial cancers

The FDA cleared an investigational new drug application for a T-cell receptor therapy designed to treat adults with solid epithelial cancers that express Kita-Kyushu lung cancer antigen 1.

News
August 31, 2021
1 min read
Save

FDA clears IND application for hormone receptor-directed CAR-T to treat ovarian cancer

FDA clears IND application for hormone receptor-directed CAR-T to treat ovarian cancer

The FDA cleared an investigational new drug application for a chimeric antigen receptor T-cell therapy designed to treat women with relapsed epithelial ovarian cancer.

News
August 19, 2021
1 min read
Save

FDA grants fast track designation to STRO-002 for advanced gynecologic cancers

FDA grants fast track designation to STRO-002 for advanced gynecologic cancers

The FDA granted fast track designation to STRO-002 for treatment of certain women with advanced gynecologic cancer.

News
August 18, 2021
2 min read
Save

FDA approves Jemperli for mismatch repair-deficient solid tumors

FDA approves Jemperli for mismatch repair-deficient solid tumors

The FDA granted accelerated approval to dostarlimab-gxly for adults with mismatch repair-deficient recurrent or advanced solid tumors that progressed on or after prior treatment and who have no satisfactory alternative therapies.

News
August 10, 2021
1 min read
Save

FDA grants priority review to Keytruda for renal cell carcinoma subset

FDA grants priority review to Keytruda for renal cell carcinoma subset

The FDA granted priority review to pembrolizumab as adjuvant therapy for certain patients with renal cell carcinoma, according to the agent’s manufacturer.

News
July 28, 2021
3 min read
Save

Screening method frequently misses endometrial cancer in Black women

Screening method frequently misses endometrial cancer in Black women

Transvaginal ultrasound used to determine appropriateness of endometrial cancer biopsy missed nearly five times more cases of the disease among Black women vs. white women, according to a simulated cohort study published in JAMA Oncology.

News
July 25, 2021
2 min read
Save

ASTRO elects three new officers

Members of American Society for Radiation Oncology elected three new officers to ASTRO’s board of directors.

News
July 24, 2021
1 min read
Save

NCI branch chief receives award for BRCA-related research

NCI branch chief receives award for <i>BRCA</i>-related research

Andre Nussenzweig, PhD, received the ninth annual Basser Global Prize.

News
July 22, 2021
2 min watch
Save

VIDEO: Less intense follow-up adequate in endometrial cancer

VIDEO: Less intense follow-up adequate in endometrial cancer

In this video, Christina M. Annunziata, MD, PhD, senior investigator at the National Cancer Institute, discussed results from the TOTEM trial presented at the ASCO Annual Meeting.

View more